Shorter radiation aimed at boosting stomach cancer treatment, cutting side effects
NCT ID NCT07101666
Summary
This study is testing a new combination of treatments for early-stage stomach cancer. It adds a shorter course of radiation to standard chemotherapy, all given before surgery. Researchers hope this approach will more completely eliminate the tumor and cause fewer severe side effects compared to current methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Contact Phone: •••-•••-••••
Contact
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Contact Phone: •••-•••-••••
Contact
-
UCLA
Los Angeles, California, 90095, United States
Contact Phone: •••-•••-••••
Contact
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.